| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.0034 | 0.9 |